TY - JOUR
T1 - Determination of treatment strategies for granular corneal dystrophy type 2 using Fourier-domain optical coherence tomography
AU - Kim, Tae Im
AU - Hong, Jin Pyo
AU - Ha, Byung Jin
AU - Stulting, R. Doyle
AU - Kim, Eung Kweon
PY - 2010/3
Y1 - 2010/3
N2 - Aim: To evaluate the use of Fourier-domain optical coherence tomography (FD-OCT) in the selection and planning of surgical procedures to treat GCD2 (granular corneal dystrophy type 2). Methods: An RTVue-100 FD-OCT (Optovue, Fremont, California) was used to determine the size, depth and location of deposits in six patients with homozygous or heterozygous GCD2. Results: The RTVue-100 FD-OCT revealed the depth of the deposits quite precisely, allowing the determination of the appropriate depth of PTK (phototherapeutic keratectomy) and the appropriate selection of lamellar versus penetrating keratoplasty as the procedure of choice. In each case, visually significant opacities were adequately removed or would be removed. Conclusion: FD-OCT provides useful information for the selection and planning of surgical procedures to remove corneal opacities in patients with GCD2.
AB - Aim: To evaluate the use of Fourier-domain optical coherence tomography (FD-OCT) in the selection and planning of surgical procedures to treat GCD2 (granular corneal dystrophy type 2). Methods: An RTVue-100 FD-OCT (Optovue, Fremont, California) was used to determine the size, depth and location of deposits in six patients with homozygous or heterozygous GCD2. Results: The RTVue-100 FD-OCT revealed the depth of the deposits quite precisely, allowing the determination of the appropriate depth of PTK (phototherapeutic keratectomy) and the appropriate selection of lamellar versus penetrating keratoplasty as the procedure of choice. In each case, visually significant opacities were adequately removed or would be removed. Conclusion: FD-OCT provides useful information for the selection and planning of surgical procedures to remove corneal opacities in patients with GCD2.
UR - http://www.scopus.com/inward/record.url?scp=77949531441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949531441&partnerID=8YFLogxK
U2 - 10.1136/bjo.2009.164525
DO - 10.1136/bjo.2009.164525
M3 - Article
C2 - 19726432
AN - SCOPUS:77949531441
SN - 0007-1161
VL - 94
SP - 341
EP - 345
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 3
ER -